
Read More
EUR 75 Million Deal: This Low PE, High ROCE Pharma Company Enters Exclusive...
Lupin's wholly owned subsidiary VISUfarma will receive exclusive rights for regulatory activities, m...

Lupin's wholly owned subsidiary VISUfarma will receive exclusive rights for regulatory activities, m...

KMC Speciality Hospitals reported a 37.90 per cent YoY increase in revenue to Rs 91.78 crore, while ...

AstraZeneca Pharma India reported Q1 FY27 revenue of Rs 682.79 crore, while profit after tax stood a...

Yatharth Hospital & Trauma Care Services shares have delivered strong returns across multiple period...

Morepen Laboratories Limited reported its highest-ever quarterly revenue and earnings in Q1 FY27, dr...

Piramal Pharma reported healthy Q1 FY27 growth across all three business segments, with strong EBITD...

Laurus Labs witnessed increased foreign institutional participation during the June 2026 quarter, wh...

Cipla reported a modest increase in revenue during Q1 FY27, while profitability declined on a high b...

Emcure Pharmaceuticals will expand the use of Poviztra® for the treatment of MASH following CDSCO ap...

NATCO Pharma approved investments of up to Rs 1,400 crore to expand its South African operations, in...